Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease

Despite the evolution in inflammatory bowel disease (IBD) management during the last 20 years owing to the advent of new advanced therapies, anti-TNF agents still remain the cornerstone of therapy for both Crohn’s disease and ulcerative colitis. However, this does not only secure favorable outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Orfanoudaki, Eleni, Foteinogiannopoulou, Kalliopi, Theodoraki, Eirini, Koutroubakis, Ioannis E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095227/
https://www.ncbi.nlm.nih.gov/pubmed/37048536
http://dx.doi.org/10.3390/jcm12072452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095227/
https://www.ncbi.nlm.nih.gov/pubmed/37048536
http://dx.doi.org/10.3390/jcm12072452

Ejemplares similares